Back

Post-TAVI pacemaker requirement prediction - simple math?

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Bleedings and conduction disturbances after aortic interventions Intervention ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Joao Fernandes Pedro

Santa Maria Hospital - CHULN, Lisbon (Portugal)

7 More presentations in this session

Presentation thumbnail
Bleeding risk in all-comer TAVI patients
Mrs S. Baleswaran Krishnapillai (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Impact of packed red blood cells administration on long-term outcomes in patients undergoing transcatheter aortic valve implantation
Doctor T. Stolte (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Assessing the CHA2DS2-VASc score in risk stratification and management of oral anticoagulation during TAVI
Doctor D. van Ginkel (Nieuwegein, NL)
Abstract Slides Video
Presentation thumbnail
Bleeding risk stratification in patients undergoing transcatheter aortic valve replacement: enhancing VARC-HBR criteria with CT-ADP as a marker of primary hemostatic disorder
Doctor S. Kikuchi (Strasbourg, FR)
Abstract Slides Video
Presentation thumbnail
Impact of short membranous septal length on overall survival after transcatheter aortic valve replacement
Doctor H. Tsurumi (Okinawa, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Bleedings and conduction disturbances after aortic interventions

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Post- TAVI care: assessing the need for cardiac device implantation
thumbnail
Congress Presentation
Permanent pacemaker implantation is associated with an increased risk of heart failure hospitalization in transcatheter aortic valve implantation patients with reduced systolic function
thumbnail
Congress Presentation
Predictors and timing of pacemaker implantation after TAVI: a retrospective analysis of early and late cases

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources